Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Manchester cohort

AJ Arthur Jochems
IE Issam El-Naqa
MK Marc Kessler
CM Charles S. Mayo
SJ Shruti Jolly
MM Martha Matuszak
CF Corinne Faivre-Finn
GP Gareth Price
LH Lois Holloway
SV Shalini Vinod
MF Matthew Field
MB Mohamed Samir Barakat
DT David Thwaites
DR Dirk de Ruysscher
AD Andre Dekker
PL Philippe Lambin
ask Ask a question
Favorite

The Manchester cohort consisted of 196 anonymized lung cancer patients with NSCLC, Stage I–IIIB. Studies was conducted under IRB approval. All patients were treated with curative intent in the period between December 2008 and May 2013. Two different protocols were used for treating patients in this dataset. One hundred twenty-one NSCLC patients received 55 Gy in 20 daily fractions (2.75 Gy per fraction), either without chemotherapy or following induction chemotherapy. Seventy-three NSCLC patients received 60–66 Gy in 30–33 daily fractions (2 Gy per fraction) with concurrent radiotherapy.

The remaining two patients received a treatment regime tailored specifically to the patient.

Copyright and License information:  ©2017
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A